Evidence map›Paper›PMID 38600493›Full record

ArticleBMC health services research2024

"So at least now I know how to deal with things myself, what I can do if it gets really bad again"-experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study.

Anne Müller, Fabian Hebben, Kim Dillen, Veronika Dunkl, Yasemin Goereci, Raymond Voltz, Peter Löcherbach, Clemens Warnke, Heidrun Golla, COCOS-MS trial group represented by Martin Hellmich

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anne MüllerDepartment of Palliative Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany. anne.mueller@uk-koeln.de.ORCID http://orcid.org/0000-0002-2456-2492
Fabian HebbenDepartment of Palliative Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0009-0003-6401-3433
Kim DillenDepartment of Palliative Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Veronika DunklDepartment of Palliative Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Yasemin GoereciDepartment of Neurology, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Raymond VoltzDepartment of Palliative Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
Peter LöcherbachGerman Society of Care and Case Management E.V. (DGCC), Münster, Germany.
Clemens WarnkeDepartment of Neurology, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-3510-9255
Heidrun GollaDepartment of Palliative Medicine, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-4403-630X
COCOS-MS trial group represented by Martin Hellmich

Funding

Innovation Funds of the Federal Joint Committee (G-BA) 01VSF19029
6 · The paper itself

Abstract

backgroundPersons with severe Multiple Sclerosis (PwsMS) face complex needs and daily limitations that make it challenging to receive optimal care. The implementation and coordination of health care, social services, and support in financial affairs can be particularly time consuming and burdensome for both PwsMS and caregivers. Care and case management (CCM) helps ensure optimal individual care as well as care at a higher-level. The goal of the current qualitative study was to determine the experiences of PwsMS, caregivers and health care specialists (HCSs) with the CCM.

methodsIn the current qualitative sub study, as part of a larger trial, in-depth semi-structured interviews with PwsMS, caregivers and HCSs who had been in contact with the CCM were conducted between 02/2022 and 01/2023. Data was transcribed, pseudonymized, tested for saturation and analyzed using structuring content analysis according to Kuckartz. Sociodemographic and interview characteristics were analyzed descriptively.

resultsThirteen PwsMS, 12 caregivers and 10 HCSs completed interviews. Main categories of CCM functions were derived deductively: (1) gatekeeper function, (2) broker function, (3) advocacy function, (4) outlook on CCM in standard care. Subcategories were then derived inductively from the interview material. 852 segments were coded. Participants appreciated the CCM as a continuous and objective contact person, a person of trust (92 codes), a competent source of information and advice (on MS) (68 codes) and comprehensive cross-insurance support (128 codes), relieving and supporting PwsMS, their caregivers and HCSs (67 codes).

conclusionsThrough the cross-sectoral continuous support in health-related, social, financial and everyday bureaucratic matters, the CCM provides comprehensive and overriding support and relief for PwsMS, caregivers and HCSs. This intervention bears the potential to be fine-tuned and applied to similar complex patient groups.

trial registrationThe study was approved by the Ethics Committee of the University of Cologne (#20-1436), registered at the German Register for Clinical Studies (DRKS00022771) and in accordance with the Declaration of Helsinki.

Indexed as

Case ManagementMultiple SclerosisCaregiversHumansLong-Term CareQualitative ResearchSocial WorkAdvocacyCare and case managementCaregiversCross-sectoralHealth care specialistLong-termPatientsQualitative researchSevere multiple sclerosisSupport

Identifiers

PMID38600493
PMCPMC11007872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.